32 / 220
臺灣農藥科學 第
1
期
30
Pesticide Sex Endpoint
BM
4)
AIC SR
5)
P BMD BMDL
BMD/
BMDL
RN
6)
NA Hepatoad-
enoma
LL 261 -0.002 0
90 11
8.18
NA Hepatoad-
enoma
G 379 0.001 0
163 23
7.09
NA Hepatoad-
enoma
LL 248 0.32 0
3
2
1.5
NA Thyroid
lesion
LP 133 -0.01 0
4.2
1.1
3.82
Iprodi-
one
NA Space be-
tween body
wall and
organ
LL 116 -0.09 0.76 79
13
6.08 (38)
NA Small fetus LL 104 0.42 0.86 38
16
2.38
NA Benign and
malignant
liver tumor
M 132 -0.22 1
213
72
2.96
NA Lutemoa
LL 104 -0.72 0.08 172
93
1.85
8,9-ziso-
mer of
avermec-
tin B1
NA Left palate,
fetus bsais
LL 60 -0.16 0.99 0.06 0.03 2
(3)
Aver-
mectin
NA Left palate,
fetus bsais
M 100 0.05 0.94 0.39 0.12 3.25 (3)
Chlor-
pyrifos-
methyl
NA Adrenal
vacuolation
LL 141 -1.6 0.10 22
1.72 12.8 (15)
Thiod-
carb
NA Liver
masses
LL 139 -0.01 0.41 71
35
2.03 (61, 62)
NA Kidney
mineral
deposit
LL 266 0.14 0.81 35
22
1.59
表一、分析
31
種農藥之基準劑量與其最適模式、相關參數及資料來源（續）
Table 1.
Parameters and source of BMD analysis for the 31 pesticide risk assessment models
(continued)